A Comparative Study of Two Kinds of Hemodialysis Filters
Uremia
About this trial
This is an interventional treatment trial for Uremia focused on measuring Hemodialysis Filter, OCI-HF160, FX800HDF
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 years, gender not limited; Patients with clinical diagnosis of chronic renal insufficiency (CKD stage 5) requiring renal replacement therapy; Dialysis access was central venous catheter; Newly placed tubing, not dialysed patients; (5) patients voluntarily participated and written informed consent signed by the patient or authorized delegate had been obtained. Exclusion Criteria: Patients with acute renal failure; Patients are participating in other clinical studies; Pregnancy or breastfeeding; Use of hemostatic or anticoagulant drugs in the last 1 week; Positive infectious serum markers for HIV, syphilis, hepatitis B, and hepatitis C; Presence of active infection; Allergy to dialyzers.
Sites / Locations
- Chinese PLA General Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Group A(OCI-HF160+FX800HDF)
Group B(FX800HDF+OCI-HF160)
Group A first used the hemodialysis filter OCI-HF160, then used FX800HDF.
Group B first used the hemodialysis filter FX800HDF, and then used OCI-HF160.